Israeli study finds 94% drop in symptomatic Covid-19 cases with Pfizer vaccine | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
June 20, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JUNE 20, 2025
Israeli study finds 94% drop in symptomatic Covid-19 cases with Pfizer vaccine

Coronavirus chronicle

Reuters
15 February, 2021, 08:55 am
Last modified: 15 February, 2021, 12:51 pm

Related News

  • Regime change in Iran: Will history repeat itself as a farce this time?
  • Seeds of conflict: How a historic betrayal laid the groundwork for Iran-Israel enmity
  • No evidence Iran is actively pursuing nuclear weapons: IAEA chief
  • Bombing Iran's nuclear sites won't cause Chernobyl-like disaster: Experts
  • Gaza rescuers say 18 killed by Israeli fire

Israeli study finds 94% drop in symptomatic Covid-19 cases with Pfizer vaccine

Researchers at the Weizmann Institute of Science said that a sharp decline in hospitalisation and serious illness identified earlier among the first age group to be vaccinated - aged 60 or older - was seen for the first time in those aged 55 and older

Reuters
15 February, 2021, 08:55 am
Last modified: 15 February, 2021, 12:51 pm
A woman reacts while receiving a vaccination against the coronavirus disease (COVID-19) as Israel continues its national vaccination drive, in East Jerusalem December 23, 2020. REUTERS/Ammar Awad//File Photo
A woman reacts while receiving a vaccination against the coronavirus disease (COVID-19) as Israel continues its national vaccination drive, in East Jerusalem December 23, 2020. REUTERS/Ammar Awad//File Photo

Israel's largest healthcare provider on Sunday reported a 94% drop in symptomatic Covid-19 infections among 600,000 people who received two doses of the Pfizer's vaccine in the country's biggest study to date.

Health maintenance organization (HMO) Clalit, which covers more than half of all Israelis, said the same group was also 92% less likely to develop severe illness from the virus.

The comparison was against a group of the same size, with matching medical histories, who had not received the vaccine.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"It shows unequivocally that Pfizer's coronavirus vaccine is extremely effective in the real world a week after the second dose, just as it was found to be in the clinical study," said Ran Balicer, Clalit's chief innovation officer.

He added that the data indicates the Pfizer vaccine, which was developed in partnership with Germany's BioNTech, is even more effective two weeks or more after the second shot.

Researchers at the Weizmann Institute of Science, who have been tabulating national data, said on Sunday that a sharp decline in hospitalisation and serious illness identified earlier among the first age group to be vaccinated - aged 60 or older - was seen for the first time in those aged 55 and older.

Hospitalisations and serious illness were still rising in younger groups who began vaccinations weeks later.

Israel has been conducting a rapid vaccine rollout and its database offers insights into vaccine effectiveness and at what point countries might attain herd immunity.

Top News

Pfizer Covid-19 Vaccine / Israel / Study finding / Pfizer coronavirus vaccine / Pfizer-19 Vaccine / Pfizer-BioNTech vaccine / Pfizer-BioNTech coronavirus vaccine / Pfizer vaccine / vaccine data / Vaccine efficacy / Vaccine / Coronavirus Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • A building at the campus of the Weizmann Institute of Science remains damaged following an Iranian missile strike on Sunday, in Rehovot, Israel June 19, 2025. REUTERS
    Israeli military says it bombed Iranian missile launch platform, kills commander: Al Jazeera
  • A pumpjack operates at the Vermilion Energy site in Trigueres, France, June 14, 2024. REUTERS/Benoit Tessier/File Photo
    Oil prices up nearly 3% as Israel-Iran conflict escalates, US response remains uncertain
  • Infographic: TBS
    $3.6b budget support expected by month-end

MOST VIEWED

  • BAT Bangladesh to shut Mohakhali factory, relocate HQ after lease rejection
    BAT Bangladesh to shut Mohakhali factory, relocate HQ after lease rejection
  • Mashrur Arefin appointed Chairman of the Association of Bankers Bangladesh
    Mashrur Arefin appointed Chairman of the Association of Bankers Bangladesh
  • Illustration: Ashrafun Naher Ananna/TBS Creative
    From 18m to 590m francs: Deposits from Bangladeshis fly high in Swiss banks in 2024
  • Students attend their graduation ceremony. REUTERS/Brian Snyder/File Photo
    US resumes student visas but orders enhanced social media vetting
  • Emergency workers at Soroka Medical Center after an Iranian missile strike, Israel June 19, 2025. Photo: Reuters
    Khamenei 'cannot continue to exist', Israeli defence minister says after hospital strike
  • Representational image. Photo: Bloomberg
    NBR’s policy reversal jolts oceangoing shipping, $3.5b investment, $1b yearly freight at risk

Related News

  • Regime change in Iran: Will history repeat itself as a farce this time?
  • Seeds of conflict: How a historic betrayal laid the groundwork for Iran-Israel enmity
  • No evidence Iran is actively pursuing nuclear weapons: IAEA chief
  • Bombing Iran's nuclear sites won't cause Chernobyl-like disaster: Experts
  • Gaza rescuers say 18 killed by Israeli fire

Features

BUET Professor Md Ehsan stands beside his newly designed autorickshaw—just 3.2 metres long and 1.5 metres wide—built for two passengers to ensure greater stability and prevent tipping. With a safety-focused top speed of 30 km/h, the vehicle can be produced at an estimated cost of Tk1.5 lakh. Photo: Junayet Rashel

Buet’s smart fix for Dhaka's autorickshaws

5h | Features
Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

1d | Panorama
The Kallyanpur Canal is burdened with more than 600,000 kilograms of waste every month. Photo: Courtesy

Kallyanpur canal project shows how to combat plastic pollution in Dhaka

2d | Panorama
The GLS600 overall has a curvaceous nature, with seamless blends across every panel. PHOTO: Arfin Kazi

Mercedes Maybach GLS600: Definitive Luxury

4d | Wheels

More Videos from TBS

US joining Israeli strikes would cause hell: Iranian minister

US joining Israeli strikes would cause hell: Iranian minister

2h | TBS World
Bribery exposed: BBS report reveals year’s dark data

Bribery exposed: BBS report reveals year’s dark data

16h | TBS Today
Is the story of nuclear weapons just to justify military operations?

Is the story of nuclear weapons just to justify military operations?

17h | TBS World
What are the political parties saying about the presidential election and power?

What are the political parties saying about the presidential election and power?

17h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net